Evernorth EncircleRx: Cardiodiabesity Vendor+ program

A new program that creates a pathway for clients to partner through their preferred weight loss management vendor in our platform.

woman running
Clients notified by account teams starting on September 2, 2025

Evernorth EncircleRx : Cardiodiabesity Vendor+ Program

Clients have shared that they would like the flexibility to include virtual care vendors that they have built a valued and trusted relationship within their EncircleRx weight loss program.

 people at table
Starting January 1, 2026

More vendor choice with specialized providers and a narrow network

Evernorth EncircleRxSM Vendor+ creates a pathway for clients who want to leverage their relationship with a preferred vendor listed below to manage weight loss within our EncircleRx platform. This program requires collaboration between the vendor and Evernorth, which enables a narrow network of providers that specialize in obesity to prescribe GLP-1s to clinically appropriate patients.


In addition to prescribing GLP-1s, the vendor’s prescribers offer a personalized treatment experience within a virtual care environment while keeping the member’s primary care provider informed.

man with stethoscope

EncircleRx Vendor+ partners

We have partnered with the following vendors as part of the EncircleRx Vendor+ program to combine telehealth with medical and personalized weight loss support that allows patients to monitor and track progress: 

form health logo
virta logo
vida logo

Clients benefit from having more flexibility to continue supporting members through their contracted vendors while maintaining utilization oversight, promoting appropriate GLP-1 use and improved clinical outcomes.

What you need to know

EncircleRx Vendor+ client enrollment requirements include:

Current relationship with EncircleRx Vendor+ vendor partner

No financial guarantees

No prior authorizations

Clients will be notified by account teams starting on September 2, 2025

Questions? Contact our team.

FOR CONSULTANT/BROKER USE ONLY. Please keep this information confidential and do not share outside of your firm.